WOCKHARDT
|
The Current P/E Ratio of WOCKHARDT is -433.75.
| Share Price | ₹1,361.3 | Nov 12,2025 |
| Market Cap | ₹22,121.1 Cr | |
| Earnings-TTM | ₹-51.0 Cr | TTM-Consolidated Results |
| Price/Earnings | -433.75x | Calculated as Market Cap/Earnings |
|---|---|---|
| Explore Stock Analytics | ||
Definition & Calculation of PE (Price/Earnings) ratio of WOCKHARDT
P/E =
Market Capitalization
/ Net Income
or, using per-share numbers:
P/E = Stock Price /
Earnings Per Share (EPS)
Current Market Cap [ ₹22,121.1 Cr] as on Nov 12,2025
(/) Earnings [ ₹-51.0 Cr] based on TTM-Consolidated Results
(=) P/E Ratio [ -433.75x ]
Thus, for WOCKHARDT , the investors are currently willing to pay -433.75 times earnings to own 1 share of the company.
PE Multiples are the most widely used valuation multiple in practice.
Since P/E ratio uses Net Income in the calculation, P/E multiples are not always reliable for valuing companies with negative earnings.
In such cases, you may consider using Price to Book ratio or Price to Sales ratio of WOCKHARDT !
P/E ratios, also, would not adjust for differences in the capital structure between companies.
The chart below summarizes the trend in P/E Ratio of WOCKHARDT over the last five years.
Historical PE (Price/Earnings) ratio chart of WOCKHARDT
PE Ratio Performance Analysis for WOCKHARDT
- WOCKHARDT 's p/e ratio for fiscal years ending Mar2025 to Mar2021 averaged 1.22x.
- WOCKHARDT 's operated at median p/e ratio of 0x from fiscal years ending March 2018 to 2022.
- Looking back at the last 5 fiscal years, WOCKHARDT 's p/e ratio peaked in Mar2021 at 6.12x.
- WOCKHARDT 's p/e ratio hit its five-year low in Mar2025 of 0x.
How does WOCKHARDT 's P/E Ratio benchmark against top 10 peers in Pharmaceuticals & Drugs Industry?
| Peer Comparison (Pharmaceuticals & Drugs Industry) | Earnings-TTM (Cr) | PE Ratio | Market Cap |
|---|---|---|---|
| WOCKHARDT | -51.00 | -433.75 | 22,121.1 |
| SUN PHARMACEUTICAL INDUSTRIES LTD | 10,517.90 | 39.51 | 415,529.0 |
| DIVIS LABORATORIES LTD | 2,485.00 | 69.64 | 173,067.0 |
| CIPLA LTD | 5,453.86 | 22.51 | 122,773.0 |
| TORRENT PHARMACEUTICALS LTD | 2,140.00 | 60.46 | 129,376.0 |
| DR REDDYS LABORATORIES LTD | 5,721.40 | 17.93 | 102,595.0 |
| MANKIND PHARMA LTD | 1,767.06 | 53.10 | 93,824.1 |
| ZYDUS LIFESCIENCES LTD | 4,973.40 | 19.24 | 95,713.0 |
| LUPIN LTD | 4,347.53 | 21.39 | 92,989.9 |
| AUROBINDO PHARMA LTD | 3,447.75 | 20.02 | 69,007.9 |
| ABBOTT INDIA LTD | 1,508.95 | 41.63 | 62,818.1 |
Pharmaceuticals & Drugs Industry Benchmark (Top 10) PE Analysis vs WOCKHARDT 's P/E Ratio
| Top 10 Industry Peers | PE Ratio |
|---|---|
| Min industry PE | -433.75x |
| Max industry PE | 69.64x |
| Median industry PE | 22.51x |
| Average industry PE | -6.21x |
You may also like the below Video Courses